CTLA4 and hepatocellular carcinoma: A study combining PD-L1 and CTLA-4 blockade showed that most TRAEs in HBV+ HCC were dermatological signs and elevated laboratory indices for liver function, including pruritus, rash, increased ALT level, and increased AST level (66).